Back to today’s briefing

Story perspectives

US Drug Spending Hits $800 Billion: Urgent Reform Needed

4/1/2025

46 9

Summary

Story summary

In 2024, U.S. prescription drug spending soared to nearly $800 billion, with branded medications making up a staggering 84% of costs while only representing 9% of prescriptions. Urgent reforms to monopolies from the Hatch-Waxman Act and BPCIA are essential to lower prices and foster competition, with a proposed "one-and-done" monopoly offering hope for better access to affordable medications.

1 of 1

Story summary

In 2024, U.S. prescription drug spending soared to nearly $800 billion, with branded medications making up a staggering 84% of costs while only representing 9% of prescriptions. Urgent reforms to monopolies from the Hatch-Waxman Act and BPCIA are essential to lower prices and foster competition, with a proposed "one-and-done" monopoly offering hope for better access to affordable medications.